A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal
NCT00778349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2008-10-23
Summary
To assess the food effect on pharmacokinetic profile of metformin liquid 100 mg/mL of Ranbaxy Laboratories in healthy, adult, human subjecis following a dose administration of 10 mL (1000 mg) under fasting conditions, after a Iow fat meal and after a high fat meal
Conditions
- Healthy
Interventions
- DRUG
-
Metformin solution 100 mg/mL
Sponsors & Collaborators
-
Ranbaxy Laboratories Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-04-30
- Primary Completion
- 2002-05-31
- Completion
- 2002-07-31
More Related Trials
-
A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions
NCT00865033 ·Status: COMPLETED ·Phase: PHASE1
-
Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)
NCT01747083 ·Status: COMPLETED ·Phase: PHASE1
-
Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
NCT05123781 ·Status: COMPLETED ·Phase: PHASE1
-
PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults
NCT07300007 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions
NCT00778466 ·Status: COMPLETED ·Phase: NA
-
Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets
NCT07300059 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets
NCT07300046 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability
NCT01211197 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions
NCT00882882 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions
NCT00865839 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition
NCT01160042 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects
NCT00944177 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions
NCT00865072 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers
NCT01216397 ·Status: COMPLETED ·Phase: PHASE1
-
Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers
NCT05124730 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting Conditions
NCT00864669 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets
NCT07300033 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions
NCT00865852 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects
NCT02223026 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects
NCT02109679 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg
NCT03787043 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants
NCT03467971 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers
NCT02712619 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects
NCT02276274 ·Status: COMPLETED ·Phase: PHASE3
-
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions
NCT00865748 ·Status: COMPLETED ·Phase: PHASE1